Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzyme Engineering . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110777125B details a novel Y127W mutant enzyme for high-concentration synthesis of chiral piperidine intermediates, offering significant cost reduction in API manufacturing.
Patent CN121495896A reveals enhanced enzyme catalysis for chiral amine synthesis offering significant cost reduction and supply chain reliability for agrochemical manufacturing.
Patent CN113930415A details a novel enzymatic route for antifungal intermediates, offering high stereoselectivity and simplified purification for scalable manufacturing.
This report analyzes patent CN115747194B detailing enzymatic synthesis improvements. It highlights supply chain stability and cost efficiency for global pharmaceutical intermediate procurement strategies.
Patent CN109609474B reveals a high-efficiency amino acid dehydrogenase mutant for L-glufosinate production, offering significant cost reduction and supply chain reliability.
Patent CN116574707B reveals high-activity LeuDH mutant for L-tert-leucine. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity.
Patent CN110714002B discloses a highly efficient nitrilase mutant for synthesizing (S)-3-cyano-5-methylhexanoic acid, offering superior stereoselectivity and solubility for scalable pharmaceutical manufacturing.
Patent CN112280755B reveals mutant enzyme technology for GHK tripeptide. Achieve high yield and purity with scalable enzymatic processes for cosmetic and pharma applications.
Patent CN113444702B reveals high-efficiency OYE1 mutant for Brivaracetam intermediate production, offering superior conversion and ee values for scalable API manufacturing.
Patent CN114940964B reveals efficient UDCA production. Reduced costs and high purity for pharmaceutical supply chains.